Skip to content
Screener

Halozyme Therapeutics HALO EBITDA margin

EBITDA margin at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
25.9%+0.8pp
AMP
Amphastar PharmaceuticalsAMPH
23.5%-9.3pp
AptarGroup logo
AptarGroupATR
19.3%-2.2pp
Opko Health logo
Opko HealthOPK
7.1%+4.1pp
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
-110.1%+99.1pp
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
-61.1%-16.4pp

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$9.91B+36.0%
Enterprise value$11.93B+36.1%
P/E13.8×-3.9×
P/S6×-0.2×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×

Where this comes from

Calculated from Halozyme Therapeutics’s reported figures.

ebitda/total revenue=60.2%

Based on trailing twelve months.

The source filing: Halozyme Therapeutics’s 10-Q, filed November 3, 2025. Open the filing →

Filed
Nov 3, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001159036-25-000045

FAQ

What is Halozyme Therapeutics's EBITDA margin?
Halozyme Therapeutics (HALO) reported EBITDA margin of 60.2% in Q3 2025.
How has Halozyme Therapeutics's EBITDA margin changed year-over-year?
Halozyme Therapeutics's EBITDA margin increased by 17.0% year-over-year, from 51.5% to 60.2%.
What is the long-term trend for Halozyme Therapeutics's EBITDA margin?
Over 4 years (2020 to 2024), Halozyme Therapeutics's EBITDA margin has grown at a 0.1% compound annual growth rate (CAGR), from 55.1% to 55.3%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

Ask your AI about Halozyme Therapeutics's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude